Eventide Asset Management, Llc
- Regulatory AUM
- $7.4B
- Discretionary
- $7.4B
- Clients
- 38
- Avg AUM / client
- $194M
- Accounts
- 38
- Employees
- 69
AUM over time
Annual snapshots from Form ADV filings · as of Mar 27, 2026
Investments (13F portfolio — 278 positions, $6,046,579,443)
13F period Mar 31, 2026| # | Issuer | Class | Value | Shares | % of 13F | % of AUM |
|---|---|---|---|---|---|---|
| 1 | Guardant Health Inc | COM | $218,087,540 | 2,362,379 | 3.61% | 2.96% |
| 2 | Trane Technologies Plc | SHS | $169,041,266 | 406,555 | 2.8% | 2.29% |
| 3 | Lam Research Corp | COM NEW | $146,558,759 | 688,402 | 2.42% | 1.99% |
| 4 | Mirum Pharmaceuticals Inc | COM | $130,113,298 | 1,408,871 | 2.15% | 1.76% |
| 5 | Targa Res Corp | COM | $125,812,678 | 502,287 | 2.08% | 1.71% |
| 6 | Xometry Inc | CLASS A COM | $120,783,234 | 2,960,239 | 2.0% | 1.64% |
| 7 | Ge Vernova Inc | COM | $115,582,709 | 133,200 | 1.91% | 1.57% |
| 8 | Old Dominion Freight Line In | COM | $115,478,767 | 591,691 | 1.91% | 1.57% |
| 9 | Scholar Rock Hldg Corp | COM | $107,919,952 | 2,197,385 | 1.78% | 1.46% |
| 10 | Argenx Se | SPONSORED ADR | $91,736,042 | 125,657 | 1.52% | 1.24% |
| 11 | Asml Hldg Nv | N Y REGISTRY SHS | $89,899,679 | 68,110 | 1.49% | 1.22% |
| 12 | Irhythm Holdings Inc | COM | $89,770,578 | 760,825 | 1.48% | 1.22% |
| 13 | Insmed Inc | COM PAR $.01 | $89,293,151 | 546,310 | 1.48% | 1.21% |
| 14 | Axsome Therapeutics Inc. | COM | $87,776,957 | 519,558 | 1.45% | 1.19% |
| 15 | Vaxcyte Inc | COM | $79,840,223 | 1,374,292 | 1.32% | 1.08% |
| 16 | Entergy Corp New | COM | $76,547,994 | 682,847 | 1.27% | 1.04% |
| 17 | Vistra Corp | COM | $73,975,449 | 492,711 | 1.22% | 1.0% |
| 18 | United Rentals Inc | COM | $71,208,666 | 97,795 | 1.18% | 0.97% |
| 19 | Liberty Energy Inc | COM CL A | $69,215,809 | 2,403,098 | 1.14% | 0.94% |
| 20 | Toast Inc | CL A | $65,957,927 | 2,488,669 | 1.09% | 0.89% |
| 21 | Mettler Toledo International | COM | $63,967,861 | 50,751 | 1.06% | 0.87% |
| 22 | Monolithic Pwr Sys Inc | COM | $63,372,853 | 58,154 | 1.05% | 0.86% |
| 23 | Royalty Pharma Plc | SHS CLASS A | $62,604,127 | 1,312,534 | 1.04% | 0.85% |
| 24 | Nvent Elec Plc | SHS | $61,632,213 | 523,557 | 1.02% | 0.84% |
| 25 | Williams Cos Inc | COM | $60,517,965 | 832,248 | 1.0% | 0.82% |
Top 25 of 278 positions from the manager's latest Form 13F · source filing (EDGAR) ↗. 13F covers long US-listed positions only. "% of AUM" is share of the firm's total regulatory AUM (Form ADV Item 5.F).
Who they serve
| Client type | Clients | AUM | % of AUM |
|---|---|---|---|
| Investment companies | 14 | $7.1B | 96.1% |
| Pooled investment vehicles (non-investment companies) | 2 | $98.8M | 1.34% |
| Charitable organizations | 11 | $164M | 2.22% |
| Other investment advisers | 1 | $23.1M | 0.31% |
| Corporations and other businesses | 10 | $2.6M | 0.04% |
Private funds (1)
Reported in Form ADV Section 7.B.(1), filing of Oct 2024 · $66.4M combined gross assets
| Fund | Type | Domicile | Gross assets | Owners |
|---|---|---|---|---|
| Eventide Healthcare Innovation Fund I Lp (F/K/A Eventide Healthcare Vc Fund I Lp) | Venture Capital Fund | Delaware | $66.4M | 58 |
People (7)
roster as of Jul 20, 2026| Name | Role / title | Credentials | With firm since | Ownership |
|---|---|---|---|---|
| Kuruvilla, Finny, George | Co Chief Investment Officer And Founding Member | Apr 2008 (18y) | 50% – 75% | |
| Myhre, Jason, Lewis | Founding Member | Jan 2011 (16y) | 10% – 25% | |
| John, Robin, Cheriakalath | Chief Executive Officer And Founding Member | Dec 2012 (14y) | 25% – 50% | |
| Mathew, Sean | Chief Financial Officer | Oct 2020 (6y) | Less than 5% | |
| Reiche, Jennifer, Mortimer | Chief Compliance Officer | May 2022 (4y) | Less than 5% | |
| Luiso, Peter, Joseph | General Counsel | Jul 2023 (3y) | Less than 5% | |
| Stuart L Slack | Registered representative | Jan 2018 (9y) |
Undisclosed: 0% – 15% of the firm is not attributable from the filed Schedule A bands.
Roster from the IAPD representatives feed; ownership and acquisition dates from Form ADV Schedule A/B. "Since" is the earliest filed registration or acquisition date.
Private funds (1, $66.4M gross assets)
| Fund | Type | Gross assets | Min. investment | Owners |
|---|---|---|---|---|
| Eventide Healthcare Innovation Fund I Lp (F/K/A Eventide Healthcare Vc Fund I Lp) | Venture Capital Fund | $66.4M | $3.0M | 58 |
From Form ADV Section 7.B private fund reporting.
Documents (1 archived)
| Form | Period | Size | |
|---|---|---|---|
| Form ADV (full filing) | 03/27/2026 | 1.52 MB | View · PDF · Source ↗ |
Archived copies of the firm's regulatory filings, versioned by content hash.
Disciplinary disclosures
No disciplinary events reported on the firm's latest Form ADV filing.
How they charge
- • Percentage of assets under management
- • Performance-based fees
- • Other fees
- • A PERCENTAGE OF ASSETS UNDER ADVISEMENT
Services
- • Portfolio management for investment companies
- • Portfolio management for pooled investment vehicles
- • Portfolio management for businesses/institutional clients
- • Selection of other advisers
- • Educational seminars/workshops
- • Other services
Custody
Reported custodians
- U.S. Bank $139M (2% of AUM) Mar 2026
- Morgan Stanley $23.1M (0% of AUM) Mar 2026
- Fidelity Brokerage Services $9.8M (0% of AUM) Oct 2025
Amounts as reported in ADV Item 5.K.(3) (custodians holding 10%+ of SMA assets).
Firm reports it does not have custody of client funds or securities (Item 9.A).
Source
All data on this page comes from this firm's Form ADV filings, reproduced without modification. Latest filing: Mar 27, 2026.
View current Form ADV (SEC/IAPD) ↗